Covered recipient · General Payments record
MARISA AGUIRRE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,355.90
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.72 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $66.82 | 2 |
| Lilly USA, LLC | $37.95 | 2 |
| Amgen Inc. | $33.71 | 2 |
| Otsuka America Pharmaceutical, Inc. | $28.39 | 1 |
| GlaxoSmithKline, LLC. | $18.25 | 1 |
| Novo Nordisk AS | $17.17 | 1 |
| Merck Sharp & Dohme Corporation | $16.35 | 1 |
| PFIZER INC. | $14.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.38 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117185617 | CMS |
| Amgen Inc. | $17.33 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117185619 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.91 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105638420 | CMS |
| AstraZeneca Pharmaceuticals LP | $49.91 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105511119 | CMS |
| GlaxoSmithKline, LLC. | $18.25 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116655261 | CMS |
| Lilly USA, LLC | $17.28 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135155987 | CMS |
| Lilly USA, LLC | $20.67 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166686 | CMS |
| Merck Sharp & Dohme LLC | $16.35 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141959434 | CMS |
| Novo Nordisk Inc | $17.17 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097138268 | CMS |
| Otsuka America Pharmaceutical, Inc. | $28.39 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118848964 | CMS |
| PFIZER INC. | $14.08 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032078 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.